EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 24.00
-0.60 (-2.44%)
Apr 17, 2026, 8:00 AM GMT
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 105.9 million as of April 17, 2026. Its market cap has increased by 0.36% in one year.
Market Cap
105.90M
Enterprise Value
94.83M
Revenue
51.56M
Ranking
n/a
PE Ratio
52.35
Stock Price
24.00
Market Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 105.90M, an increase of 4,558.14%. That is a compound annual growth rate of 18.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 105.90M | -7.56% |
| Dec 31, 2025 | 114.57M | -6.48% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.02B |
| GSK plc | 85.13B |
| Haleon | 31.48B |
| Smith & Nephew | 10.78B |
| Scancell Holdings | 140.10M |
| Diaceutics | 139.68M |
| Shield Therapeutics | 99.90M |
| Bioventix | 94.05M |